Trifarotene Vehicle Cream

DRUG2 trials

Sponsors

Galderma R&D

Conditions

Acne Vulgaris

Phase 4

Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation

CompletedNCT04856904

Galderma R&DAcne Vulgaris

Start: 2021-05-28End: 2023-06-30Updated: 2024-06-11

AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation

CompletedNCT05089708

Galderma R&DAcne Vulgaris

Start: 2021-12-22End: 2022-12-15Updated: 2023-12-20

Related Papers

Patient Insights on Acne Hyperpigmentation, Trifarotene, and Skincare: 6-Month, LEAP Phase 4 Qualitative Exit Interview Findings.

2025-11-24

Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.

2023-10-1511 citations